CLINICAL_TRIALS
trial_result
· 2013-09-27
Clinical Trial Update: Metabolic Effects of Paricalcitol [Phase 2]
Summary
Phase 2 trial assessing metabolic effects of paricalcitol in chronic kidney disease; the study has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-09-27